Business OpportunityUpdated on 12 October 2025
Developing a new therapy for the treatment of diabetes mellitus
Entrepreneur at ACCIÓ
Barcelona, Spain
About
Engineered Regulatory T-cells to express specific receptors to modulate and restore the immune balance. Experimental validation already done, including preclinical studies and prototype testing. Looking for testing in a realistic environment, clinical trials, and final manufacturing/submission processes.
Stage
- TRL 6
Topic
- Diseases of the blood and immune disorders
- Endocrine/nutritional/metabolic diseases
Sector
- ATMPs
Type
- Co-development
- Regulatory expert
- Consortium partners
Organisation
Similar opportunities
Business Opportunity
- TRL 6
- TRL 7
- TRL 8
- Health data
- Rare diseases
- Research collaboration
- Congenital or chromosomal abnormalities
- Diseases of the blood and immune disorders
Jacques Riviere
Pediatric immunologist, researcher at Vall d'Hebron Research Institute (VHIR)
Barcelona, Spain
Business Opportunity
- TRL 6
- TRL 7
- TRL 8
- ATMPs
- Rare diseases
- Cardiovascular
- Co-development
- Digestive system
- Diseases of the ear
- Diseases of the eye
- Consortium partners
- Genitourinary system
- Research collaboration
- Skin and subcutaneous tissue
- Musculoskeletal system, connective tissue
- Diseases of the blood and immune disorders
- Diseases of the nervous system / neurology
Friederike Eilts
Team lead process technologies at Fraunhofer IGB
Business Opportunity
- TRL 6
- Other
- Other
- Genomics
- Oncology
- Proteomics
- Licensing
- Health data
- Bioinformatics
- Co-development
- Regulatory expert
- Clinical validation
- Consortium partners
- Research collaboration
- Neoplasms/cancer/oncology
- Diseases of the blood and immune disorders
Giovanni Roti
Prof. Hematology - Head THEC lab at University of Parma
Parma, Italy